This is a co-marketing form for distributors. There is a restricted space on the cover next to the Lonza logo and on the back below the market bar. Art for placement MUST be a PDF. In addition there is space on the back cover for a web address at the top and contact and disclaimers.   Please look for the instruction PDF in the literature DB Article number CD-FO006Inst

Technical information sheet for Clonetics™ Coronary Artery Endothelial Cells

Technical information sheet for Clonetics™ Iliac Artery Endothelial Cells

Technical information sheet for CloneticsTM HUVEC cells

Protocol for Angiogenesis assay using HUVEC cells

Instructions for culturing Clonetics™ HIVEC-XL™Pooled Cells

With the prevalence of diabetes growing worldwide, the availability of primary human cells from diabetic donors is critical to increase research and knowledge about the disease at a cellular level. In this study, we sought to identify genes differentially regulated in diabetic type 1 and type 2 adipose-derived stem cells (ADSCs) and human aortic endothelial cells (HAECs).

HUVECs are a good primary endothelial cell type for many in vitro studies and also for several high-throughput screening applications. Consequently, Lonza offers, HUVEC-XL. These cells are expanded to passage-3 from pooled P1-HUVECs and packaged at 10 million cells per ampoule.

Technical information and instructions for culturing Clonetics® Immortalized Human Dermal Blood Lymphatic Microvascular Endothelial Cells

Human Umbilical Vein Endothelial Cells seeded on BME and the formation of endothelial tubes were monitored live with the CytoSMART™ Lux 10X System, the previous version of the CytoSMART™ 2 System. Time-lapse video was recorded for 22 hours at a frame interval of 1 frame every 5 minutes.